1-8 of 8
Kami Maddocks
Close
Sort by
Journal Articles

Postinfusion PD-1 + CD8 + CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma

Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea Peterson, Yi Wang, Kelsi Reynolds, Robert M. Bolz, Jessica Miao, Chunhua Song, Dayong Wu, Wing Keung Chan, Evandro Bezerra, Narendranath Epperla, Timothy J. Voorhees, Jonathan Brammer, Adam S. Kittai, David A. Bond, Yazeed Sawalha, Audrey Sigmund, John C. Reneau, Mark P. Rubinstein, Walter Hanel, Beth Christian, Robert A. Baiocchi, Kami Maddocks, Lapo Alinari, Sumithira Vasu, Marcos de Lima, Dongjun Chung, Samantha Jaglowski, Zihai Li, Xiaopei Huang, Yiping Yang
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3140–3153.
https://doi.org/10.1182/bloodadvances.2023012073
Published: 2024
Includes: Supplemental data
Journal Articles

Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma

Clinical Trials & Observations
Tycel J. Phillips, David Bond, Radihka Takiar, Karson Kump, Malalthi Kandarpa, Philip Boonstra, Tera Lynn Mayer, Victoria Nachar, Ryan A. Wilcox, Shannon A. Carty, Yasmin H. Karimi, Zaneta Nikolovska-Coleska, Mark S. Kaminski, Alex F. Herrera, Kami Maddocks, Leslie Popplewell, Alexey V. Danilov
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4518–4527.
https://doi.org/10.1182/bloodadvances.2023009992
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Clinical Trials & Observations
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, David A. Bond, Mehdi Hamadani, Timothy S. Fenske, Peter Martin, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Lawrence D. Kaplan, David J. Inwards, Andrew L. Feldman, Eric D. Hsi, Kami Maddocks, Kristie A. Blum, Nancy L. Bartlett, James R. Cerhan, John P. Leonard, Thomas M. Habermann, Matthew J. Maurer, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2287–2296.
https://doi.org/10.1182/bloodadvances.2022009225
Published: 2023
Includes: Supplemental data
Journal Articles

Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy

Kaitlin Annunzio, Michael Cackovic, David Bond, Yazeed Sawalha, Timothy J. Voorhees, Walter Hanel, Lapo Alinari, Robert Baiocchi, John Reneau, Jonathan Brammer, Kami Maddocks, Beth Christian, Narendranath Epperla
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2241–2244.
https://doi.org/10.1182/bloodadvances.2022008621
Published: 2023
Journal Articles

Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas

Clinical Trials & Observations
Megan Fleming, Ying Huang, Emily Dotson, David A. Bond, John Reneau, Narendranath Epperla, Lapo Alinari, Jonathan Brammer, Beth A. Christian, Robert A. Baiocchi, Kami Maddocks, Yazeed Sawalha
Journal: Blood Advances
Blood Adv (2022) 6 (2): 460–472.
https://doi.org/10.1182/bloodadvances.2021005999
Published: 2022
Journal Articles

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Clinical Trials & Observations
David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami Maddocks, Michael Churnetski, Alina S. Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Brian T. Hill, Yazeed Sawalha, Peter Martin, Edward Maldonado, Max Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Nilanjan Ghosh, Steven I. Park, Narendranath Epperla, Talha Badar, Jin Guo, Mehdi Hamadani, Timothy S. Fenske, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Kristie A. Blum, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5179–5189.
https://doi.org/10.1182/bloodadvances.2021004765
Published: 2021
Includes: Supplemental data
Journal Articles

Resistance mechanism for ibrutinib in marginal zone lymphoma

Clinical Trials & Observations
Narendranath Epperla, Arwa Y. Shana’ah, Dan Jones, Beth A. Christian, Sabarish Ayyappan, Kami Maddocks, Jennifer A. Woyach
Journal: Blood Advances
Blood Adv (2019) 3 (4): 500–502.
https://doi.org/10.1182/bloodadvances.2018029058
Published: 2019
Includes: Supplemental data
Journal Articles

Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib

Clinical Trials & Observations
Tracy E. Wiczer, Lauren B. Levine, Jessica Brumbaugh, Jessica Coggins, Qiuhong Zhao, Amy S. Ruppert, Kerry Rogers, Anli McCoy, Luay Mousa, Avirup Guha, Nyla A. Heerema, Kami Maddocks, Beth Christian, Leslie A. Andritsos, Samantha Jaglowski, Steven Devine, Robert Baiocchi, Jennifer Woyach, Jeffrey Jones, Michael Grever, Kristie A. Blum, John C. Byrd, Farrukh T. Awan
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1739–1748.
https://doi.org/10.1182/bloodadvances.2017009720
Published: 2017
Includes: Supplemental data